United Therapeutics reported $5.78B in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Amarin AMRN:US USD 908.3M 64.93M
Ardelyx ARDX:US USD 144.67M 13.06M
Baxter International BAX:US USD 27.97B 3.87B
Bayer BAYN:GR EUR 131.01B 2.22B
Biocryst Pharmaceuticals BCRX:US USD 558.59M 48.06M
Biogen BIIB:US USD 24.85B 227.2M
Biomarin Pharmaceutical BMRN:US USD 6.26B 118.2M
Emergent Biosolutions EBS:US USD 2.91B 173.1M
Esperion Therapeutics ESPR:US USD 312.83M 8.85M
Gilead Sciences GILD:US USD 62.56B 313M
GlaxoSmithKline GSK:LN GBP 60.31B 28.73B
Halozyme Therapeutics HALO:US USD 1.86B 83.15M
Insmed INSM:US USD 994.82M 58.54M
Intercept Pharmaceuticals ICPT:US USD 559.4M 60.81M
Intra Cellular Therapies ITCI:US USD 782M 29.91M
Lexicon Pharmaceuticals LXRX:US USD 191.68M 79.36M
Moderna Inc MRNA:US USD 26.06B 13M
Omeros OMER:US USD 457.55M 111.91M
Ptc Therapeutics PTCT:US USD 1.58B 227.66M
Regeneron Pharmaceuticals REGN:US USD 27.68B 472M
Sangamo Biosciences SGMO:US USD 593.91M 23.21M
Sarepta Therapeutics SRPT:US USD 3.16B 159.3M
Seattle Genetics SGEN:US USD 3.62B 11.26M
Teva Pharmaceutical TEVA:IT USD 44.25B 1.68B
United Therapeutics UTHR:US USD 5.78B 238.3M
Vertex Pharmaceuticals VRTX:US USD 16.71B 1.12B